BioMarin Pharmaceutical | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Insmed USD -248140000 17.73M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Moderna USD -1050000000 196M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 861M 2.77B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



BioMarin Pharmaceutical Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.